Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of Lycojaponicumin B in medicine for treating lung cancer

A drug, lung cancer technology, applied in the field of anti-tumor drugs, can solve problems such as damage to normal tissues and cells, and achieve the effect of highlighting substantive characteristics

Inactive Publication Date: 2013-12-25
北海市韩能生物科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Malignant tumors are diseases that seriously threaten human life and health. Chemotherapy drugs commonly used in clinical practice can greatly damage normal tissues and cells while killing tumor cells, which limits its application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Lycojaponicumin B in medicine for treating lung cancer
  • Application of Lycojaponicumin B in medicine for treating lung cancer
  • Application of Lycojaponicumin B in medicine for treating lung cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1: the preparation of the compound Lycojaponicumin B tablet involved in the present invention:

[0013] Take 20 grams of compound Lycojaponicumin B, add 180 grams of conventional excipients for tablet preparation, mix well, and make 1000 tablets with a conventional tablet machine.

Embodiment 2

[0014] Embodiment 2: the preparation of the compound Lycojaponicumin B capsules involved in the present invention:

[0015] Get 20 grams of compound Lycojaponicumin B, add conventional auxiliary materials for preparing capsules such as 180 grams of starch, mix well, and pack into capsules to make 1000 tablets.

[0016] The following pharmacodynamic experiments will further illustrate its drug activity.

experiment example

[0017] Experimental example: The effect of Lycojaponicumin B on the proliferation of lung cancer cells cultured in vitro and its effect on normal human cells

[0018] Lung cancer cells in the logarithmic growth phase (non-small cell lung cancer cells A 549 , large cell lung cancer cells NCI-H460, lung squamous cell carcinoma cells HTB-8 and human lung squamous cell carcinoma cells QG-5) and human normal liver cells L02 were inoculated on 96-well culture plates, and the seeding volume per well was 3000-4000 Cells / 100uL and 6000 cells / 100uL; aseptically collect 15 mL of venous blood from healthy blood donors, anticoagulate with heparin, separate mononuclear cells by Ficoll density gradient centrifugation, prepare single cell suspension with RPMI1640 containing 10% fetal bovine serum, Adjust the cell concentration to 2×10 5 cells / mL, inoculated in 96-well culture plate, 100 uL per well. After 24 hours of cell culture on the above-mentioned culture plates, Lycojaponicumin B 100 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of Lycojaponicumin B in preparation of a medicine for treating lung cancer. The compound, namely the Lycojaponicumin B shows high lung cancer resisting activity, can be used for preparing a lung cancer resisting medicine and belongs to the technical field of new applications of medicines. The Lycojaponicumin B can obviously inhibit the non-small-cell lung cancer cell A549, maxicell lung cancer cell NCI-H460, squamous cell lung cancer cell HTB-8 and human lung squamous epithelium cancer cell QG-5 cultured in vitro while realizing a relatively low effect on inhibiting the human normal liver cell LO2 and the peripheral blood lymphocyte cell, thereby showing obvious selectivity. The application of the Lycojaponicumin B in preparation of the medicine for treating lung cancer is disclosed for the first time; the skeleton type of the Lycojaponicumin B belongs to a brand new skeleton type, and the inhibitory activity of the Lycojaponicumin B on lung cancer cells is unexpectedly strong.

Description

technical field [0001] The invention relates to the field of antitumor drugs, in particular to the application of Lycojaponicumin B in the preparation of antitumor drugs. Background technique [0002] Malignant tumors are diseases that seriously threaten human life and health. Chemotherapy drugs commonly used in clinical practice can greatly damage normal tissues and cells while killing tumor cells, which limits its application. It has become the direction and urgent task of current anticancer drug research to find highly efficient and low toxic drugs for treating tumors. Finding high-efficiency, low-toxic anticancer drugs has been considered an effective way. [0003] The present invention has confirmed by experiment that Lycojaponicumin B has the effect on non-small cell lung cancer cell A cultured in vitro. 549 , large cell lung cancer cell line NCI-H460, lung squamous cell carcinoma cell line HTB-8 and human lung squamous epithelial cell line QG-5 have significant inhi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/424A61P35/00
Inventor 江春平吴俊艺
Owner 北海市韩能生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com